表紙
市場調查報告書

過敏性鼻炎藥市場報告 (2020-2030年):各次市場 (鼻腔內抗組織胺藥,鼻腔內皮質類固醇,口服抗組織胺藥,免疫療法&疫苗)、地區的預測,主要企業的簡介

Allergic Rhinitis Drugs Market Report 2020-2030: Forecasts by Sub-Markets (Intranasal Antihistamines, Intranasal Corticosteroids, Oral Antihistamines, Immunotherapy & Vaccines), Geography, plus Leading Allergic Rhinitis Drugs Companies Analysis

出版商 Visiongain Ltd 商品編碼 954224
出版日期 內容資訊 英文 339 Pages
商品交期: 最快1-2個工作天內
價格
過敏性鼻炎藥市場報告 (2020-2030年):各次市場 (鼻腔內抗組織胺藥,鼻腔內皮質類固醇,口服抗組織胺藥,免疫療法&疫苗)、地區的預測,主要企業的簡介 Allergic Rhinitis Drugs Market Report 2020-2030: Forecasts by Sub-Markets (Intranasal Antihistamines, Intranasal Corticosteroids, Oral Antihistamines, Immunotherapy & Vaccines), Geography, plus Leading Allergic Rhinitis Drugs Companies Analysis
出版日期: 2020年06月29日內容資訊: 英文 339 Pages
簡介

本報告提供全球過敏性鼻炎藥市場相關調查,收益預測,近幾年的成果、成長率、市場佔有率,定性分析 (含市場動態,成長要素,機會,阻礙因素,課題),及主要企業簡介等資訊。

目錄

第1章 報告概要

第2章 摘要整理

第3章 簡介

  • 過敏概要
  • 過敏性鼻炎概要
    • 過敏性鼻炎的全球的流行
    • 過敏性鼻炎的病理生理學:IgE及肥大細胞
    • 過敏性鼻炎的症狀
    • 過敏性鼻炎的分類
    • 季節性過敏性鼻炎(花粉症)
    • 全年性過敏性鼻炎
    • 過敏性鼻炎的診斷
  • 過敏性鼻炎的治療
    • 抗組織胺藥物
    • 皮質類固醇
    • 白三烯素受體拮抗劑
    • 色甘酸
    • 充血消除劑
    • 生理食鹽水鼻噴霧
    • 免疫療法和疫苗

第4章 全球過敏性鼻炎藥市場:訂正分析

  • SWOT分析
    • 優勢
    • 弱點
    • 機會
    • 威脅
  • 波特的五力分析

第5章 全球過敏性鼻炎藥市場預測:各次級市場

第6章 鼻腔內抗組織胺藥物的預測

  • 鼻腔內抗組織胺藥物市場區隔:復甦預測(V, U, W, L)
  • 主要的鼻腔內抗組織胺藥物產品的預測
    • Dymista (Azelastine/Fluticasone)
    • Generic Intranasal Azelastine
    • Astepro (Azelastine)
    • Patanase (Olopatadine)
    • Astelin (Azelastine)
    • 其他

第7章 鼻腔內皮質類固醇的預測

  • 鼻腔內皮質類固醇市場區隔:復甦預測(V,U, W, L)
  • 主要的鼻腔內皮質類固醇產品的預測
    • Flixonase/Flonase/Flonase OTC(Fluticasone Propionate)
    • Nasonex(Mometasone)
    • Avamys/Veramyst (Fluticasone Furoate)
    • Rhinocort (Budesonide)
    • Nasacort/Nasacort-OTC (Triamcinolone)
    • Omnaris(Ciclesonide)
    • Beconase/Beconaes AQ (Beclometasone)
    • Qnasl (Beclometasone)
    • Zetonna(Ciclesonide)
    • 其他

第8章 口服抗組織胺藥物的預測

  • 口服抗組織胺藥物市場區隔:復甦預測(V, U, W, L)
  • 主要的口服抗組織胺藥產品的預測
    • Allegra/Allegra-D/Allegra OTC (Fexofenadine)
    • Claritin/Claritin OTC (Loratadine)
    • Zyrtec/Zyrtec D (Cetirizine)
    • Xyzal (Levocetirizine)
    • Clarinex(Desloratadine)
    • Allelock (Olopatadine)
    • Ebastel (Ebastine)
    • Talion (Bepotastine)
    • 其他

第9章 免疫療法及疫苗的預測

  • 免疫療法及疫苗市場區隔:復甦預測(V, U, W, L)
  • 主要的免疫療法及疫苗產品的預測
    • Staloral(草花粉過敏原萃取物)
    • Alutard SQ
    • Grazax/Grastek(Timothy Grass Pollen Allergen Extract)
    • Oralair
    • Ragwitek
    • 其他免疫療法、疫苗

第10章 其他過敏性鼻炎次市場預測

  • 其他的各市場區隔:復甦預測(V, U, W, L)

第11章 地區及主要國家的過敏性鼻炎藥市場預測

  • 全球過敏性鼻炎藥市場預測:復甦方案

第12章 北美的過敏性鼻炎藥市場:各國的市場佔有率預測

  • 北美的過敏性鼻炎藥市場預測:復甦方案
  • 北美的過敏性鼻炎藥市場:次市場預測
    • 北美的過敏性鼻炎的市場預測:各次級市場(100萬美元,AGR%):復甦方案(V, U, W, L)
  • 美國的過敏性鼻炎藥市場預測
    • 復甦方案(V, U, W, L):美國的過敏性鼻炎市場預測
  • 加拿大的過敏性鼻炎藥市場預測
    • 復甦方案(V, U, W, L):加拿大的過敏性鼻炎市場預測

第13章 歐洲的過敏性鼻炎藥市場:各國的市場佔有率預測

  • 歐洲的過敏性鼻炎藥市場預測:復甦方案
  • 歐洲的過敏性鼻炎藥市場:次市場預測
    • 歐洲的過敏性鼻炎的市場預測:各次級市場(100萬美元,AGR%):復甦方案(V, U, W, L)
  • 德國的過敏性鼻炎藥市場預測
    • 復甦方案(V, U, W, L):德國的過敏性鼻炎市場預測
  • 英國的過敏性鼻炎藥市場預測
  • 法國的過敏性鼻炎藥市場預測
  • 義大利的過敏性鼻炎藥市場預測
  • 西班牙的過敏性鼻炎藥市場預測
  • 比利時的過敏性鼻炎藥市場預測
  • 瑞士的過敏性鼻炎藥市場預測
  • 其他歐洲的過敏性鼻炎藥市場預測

第14章 亞太地區的過敏性鼻炎藥市場:各國的市場佔有率預測

  • 亞太地區的過敏性鼻炎藥市場預測:復甦方案
  • 亞太地區的過敏性鼻炎治療藥市場預測:各次級市場
  • 亞太地區的過敏性鼻炎市場預測:各次級市場(100萬美元,AGR%):復甦方案(V, U, W, L)
  • 日本的過敏性鼻炎藥市場預測
    • 復甦方案(V, U, W, L):日本的過敏性鼻炎市場預測
  • 中國的過敏性鼻炎藥市場預測
  • 印度的過敏性鼻炎藥市場預測
  • 其他亞太地區的過敏性鼻炎藥市場預測

第15章 南美的過敏性鼻炎藥市場:各國的市場佔有率預測

  • 南美的過敏性鼻炎藥市場預測:復甦方案
  • 南美的過敏性鼻炎藥市場預測:各次級市場,
    • 南美的過敏性鼻炎的市場預測:各次級市場(100萬美元,AGR%)、復甦方案(V, U, W, L)
  • 巴西的過敏性鼻炎藥市場預測
    • 復甦方案(V, U, W, L):巴西的過敏性鼻炎市場預測
  • 墨西哥的過敏性鼻炎藥市場預測
  • 阿根廷的過敏性鼻炎藥市場預測
  • 其他南美國家的過敏性鼻炎藥市場預測

第16章 中東、非洲<的過敏性鼻炎藥市場:各國的市場佔有率預測

  • 中東、非洲的過敏性鼻炎藥市場預測:復甦方案
  • 中東、非洲的過敏性鼻炎藥市場預測:各次級市場
    • 中東、非洲的過敏性鼻炎市場預測:各次級市場(100萬美元,AGR%)、復甦方案(V, U, W, L)
  • 阿拉伯聯合大公國的過敏性鼻炎藥市場預測
    • 復甦方案(V, U, W, L):UAE的過敏性鼻炎市場預測
  • 沙烏地阿拉伯的過敏性鼻炎藥市場預測
  • 南非的過敏性鼻炎藥市場預測
  • 其他MEA的過敏性鼻炎藥市場預測

第17章 過敏性鼻炎藥市場主要企業

  • ALK-Abello A/S
  • GSK
  • Johnson & Johnson
  • Kyowa Hakko Kirin
  • Merck KGaA
  • Sanofi
  • Stallergenes Greer
  • UCB S.A.
  • Boehringer Ingelheim International GmbH
  • Bayer AG
  • Novartis AG
  • AstraZeneca

第18章 結論

  • 關聯的Visiongain報告
  • Visiongain報告銷售定購泡沫

第19章 附錄A

  • 關於Visiongain
    • 附錄B
  • Visiongain報告評估泡沫
目錄
Product Code: PHA0787

Title:
Allergic Rhinitis Drugs Market Report 2020-2030
Forecasts by Sub-Markets (Intranasal Antihistamines, Intranasal Corticosteroids, Oral Antihistamines, Immunotherapy and Vaccines, Others), Intranasal Antihistamines (Dymista, Generic Intranasal Azelastine, Astepro, Patanase, Astelin, Others), Intranasal Corticosteroids (Flixonase/Flonase/Flonase OTC, Nasonex, Avamys/Veramyst, Rhinocort, Nasacort/Nasacort-OTC, Omnaris, Beconase/Beconaes AQ, Qnasl, Zetonna, Others), Oral Antihistamines (Allegra/Allegra-D/Allegra OTC, Claritin/Claritin OTC, Zyrtec/Zyrtec D, Xyzal, Clarinex, Allelock, Ebastel, Talion, Others), Immunotherapy and Vaccines (Staloral, Alutard SQ, Grazax/Grastek, Oralair, Ragwitek, Others), and Geography (North America, Latin America, Europe, Asia Pacific, MEA) Plus leading Allergic Rhinitis Drugs companies analysis.

Allergic Rhinitis Drugs-our new study reveals trends, R&D progress, and predicted revenues

Where is the Allergic Rhinitis Drugs market heading? If you are involved in this sector you must read this newly updated report. Visiongain's report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead

Our 330+ page report provides 450+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Allergic Rhinitis Drugs Market. See how to exploit the opportunities.

Forecasts to 2030 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, SWOT, and Porter's Fiver Forces Analysis), product profiles and commercial developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

Discover sales predictions for the world market and submarkets

Global Allergic Rhinitis Drugs Market by Sub-Markets

Intranasal Antihistamines

  • Dymista
  • Generic Intranasal Azelastine
  • Astepro
  • Patanase
  • Astelin
  • Others

Intranasal Corticosteroids

  • Flixonase/Flonase/Flonase OTC
  • Nasonex
  • Avamys/Veramyst
  • Rhinocort
  • Nasacort/Nasacort-OTC
  • Omnaris
  • Beconase/Beconaes AQ
  • Qnasl
  • Zetonna
  • Others

Oral Antihistamines

  • Allegra/Allegra-D/Allegra OTC
  • Claritin/Claritin OTC
  • Zyrtec/Zyrtec D
  • Xyzal, Clarinex
  • Allelock
  • Ebastel
  • Talion
  • Others

Immunotherapy and Vaccines

  • Staloral
  • Alutard SQ
  • Grazax/Grastek
  • Oralair
  • Ragwitek
  • Others

Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 17 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Belgium
  • Switzerland
  • Rest of Europe

Asia-Pacific

  • Japan
  • China
  • India
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East and Africa

  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Allergic Rhinitis Drugs Market, with a focus on this segment of these companies' operations. There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, U.S., Germany, UK and India, China in particular, will continue to achieve high revenue growth to 2030.

Leading companies and the potential for market growth

Overall world revenue for Allergic Rhinitis Drugs Market will surpass $xyz billion in 2020, our work calculates. We predict strong revenue growth through to 2030.

Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Allergic Rhinitis Drugs Market report helps you

In summary, our 330+ page report provides you with the following knowledge:

  • Revenue forecasts to 2030 for Allergic Rhinitis Drugs Market, with forecasts for Intranasal Antihistamines, Intranasal Corticosteroids, Oral Antihistamines, Immunotherapy and Vaccines, Others, each forecasted at a global and regional level- discover the industry's prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2030 for 5 regional and 17 key national markets - See forecasts for the Allergic Rhinitis Drugs market in North America, Latin America, Europe, Asia-Pacific and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Argentina, Germany, France, UK, Italy, Spain, Belgium, Switzerland, China, India, Japan, UAE, Saudi Arabia, and South Africa.
  • Prospects for established firms and those seeking to enter the market- including company profiles for Merck KGaA, Stallergenes Greer, AstraZeneca, Boehringer Ingelheim International GmbH, Bayer AG, Novartis AG, GSK, Johnson & Johnson, UCB S.A., Kyowa Hakko Kirin, ALK-Abelló A/S, and Sanofi involved in the Allergic Rhinitis Drugs Market.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain's study is for everybody needing commercial analyses for the Allergic Rhinitis Drugs Market and leading companies. You will find data, trends and predictions.

Buy our report today Allergic Rhinitis Drugs Market Report 2020-2030 : Forecasts by Sub-Markets (Intranasal Antihistamines, Intranasal Corticosteroids, Oral Antihistamines, Immunotherapy and Vaccines, Others), Intranasal Antihistamines (Dymista, Generic Intranasal Azelastine, Astepro, Patanase, Astelin, Others), Intranasal Corticosteroids (Flixonase/Flonase/Flonase OTC, Nasonex, Avamys/Veramyst, Rhinocort, Nasacort/Nasacort-OTC, Omnaris, Beconase/Beconaes AQ, Qnasl, Zetonna, Others), Oral Antihistamines (Allegra/Allegra-D/Allegra OTC, Claritin/Claritin OTC, Zyrtec/Zyrtec D, Xyzal, Clarinex, Allelock, Ebastel, Talion, Others), Immunotherapy and Vaccines (Staloral, Alutard SQ, Grazax/Grastek, Oralair, Ragwitek, Others), and Geography (North America, Latin America, Europe, Asia Pacific, MEA) . Avoid missing out by staying informed - order our report now.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Global Allergic Rhinitis Drugs Market Segmentation
  • 1.1 Allergic Rhinitis Drugs Market Definition
  • 1.2 Why You Should Read This Report
  • 1.3 What This Report Delivers
  • 1.4 Key Questions Answered By This Analytical Report Include:
  • 1.5 Who is This Report For?
  • 1.6 Methodology
  • 1.7 Frequently Asked Questions (FAQs)
  • 1.8 Associated Visiongain Reports
  • 1.9 About Visiongain

2 Executive Summary

3 Introduction

  • 3.1 Overview of Allergy
  • 3.2 Overview of Allergic Rhinitis
    • 3.2.1 The Global Prevalence of Allergic Rhinitis
    • 3.2.2 Pathophysiology of Allergic Rhinitis: IgEs and Mast Cells
    • 3.2.3 Symptoms of Allergic Rhinitis
    • 3.2.4 Classification of Allergic Rhinitis
      • 3.2.4.1 Non-Allergic Rhinitis and Mixed Rhinitis
    • 3.2.5 Seasonal Allergic Rhinitis (Hay Fever)
    • 3.2.6 Perennial Allergic Rhinitis
    • 3.2.7 Diagnosis of Allergic Rhinitis
  • 3.3 Treatment of Allergic Rhinitis
    • 3.3.1 Antihistamines
      • 3.3.1.1 First-Generation Antihistamines
      • 3.3.1.2 Second- And Third-Generation Antihistamines
    • 3.3.2 Corticosteroids
      • 3.3.2.1 First-, Second- And Third-Generation Intranasal Corticosteroids
      • 3.3.2.2 Combination Drug Products
    • 3.3.3 Leukotriene Receptor Antagonists
    • 3.3.4 Cromolyn (cromoglicic acid)
    • 3.3.5 Decongestants
    • 3.3.6 Saline Nasal Sprays
    • 3.3.7 Immunotherapy and Vaccines

4 Global Allergic Rhinitis Drugs Market: Qualitative Analysis

  • 4.1 SWOT Analysis
    • 4.1.1 Strengths
      • 4.1.1.1 OTC-Switch Facilitating Ease of Consumer Access
      • 4.1.1.2 The Established Role of Allergic Rhinitis Drugs in Treatment
      • 4.1.1.3 Allergic Rhinitis and Rising Unmet Clinical Need
      • 4.1.1.4 Rising Profile of Allergic Rhinitis In Various Regions Driving Healthcare Provision
    • 4.1.2 Weaknesses
      • 4.1.2.1 Intranasal Corticosteroids And Patients' Satisfaction Rates
      • 4.1.2.2 Increasing Penetration Of Generic Drug Products
      • 4.1.2.3 The Challenge Raised By The Low Volume Of Pipeline Developments
    • 4.1.3 Opportunities
      • 4.1.3.1 Growth In Emerging Markets Outstripping Established Markets
      • 4.1.3.2 Rx-to-OTC Switching And The Effects On Revenue Potential
      • 4.1.3.3 Combination Drug Products Providing Rising Efficacy Profiles
      • 4.1.3.4 The Emergence Of Immunotherapy In Allergic Rhinitis
    • 4.1.4 Threats
      • 4.1.4.1 Cost-Containment As A Growth Restraint
      • 4.1.4.2 Rising Cost Of APIs And Manufacturing
      • 4.1.4.3 Patent Expiries And The Resultant Loss Of Revenue
  • 4.2 Porter's Five Forces Analysis
    • 4.2.1 Power of Buyers
    • 4.2.2 Power of Suppliers
    • 4.2.3 Threat of Substitutes
    • 4.2.4 Threat 0f New Entrants
    • 4.2.5 Rivalry Among Competitors

5 Global Allergic Rhinitis Drugs Market Size Forecast 2020-2030 by Sub Markets

6 Intranasal Antihistamines Forecast 2020-2030

  • 6.1 Global Allergic Rhinitis Drugs Market for Intranasal Antihistamines Segment: Recovery Forecasts (V,U, W, L)
  • 6.2 Leading Intranasal Antihistamines Products Forecast, 2020-2030
    • 6.2.1 Dymista (Azelastine/Fluticasone) Forecast 2020-2030
    • 6.2.2 Generic Intranasal Azelastine Forecast 2020-2030
    • 6.2.3 Astepro (Azelastine) Forecast 2020-2030
    • 6.2.4 Patanase (Olopatadine) Forecast 2020-2030
    • 6.2.5 Astelin (Azelastine) Forecast 2020-2030
    • 6.2.6 Others Forecast 2020-2030

7 Intranasal Corticosteroids Forecast 2020-2030

  • 7.1 Global Allergic Rhinitis Drugs Market for Intranasal Corticosteroids Segment: Recovery Forecasts (V,U, W, L)
  • 7.2 Leading Intranasal Corticosteroids Products Forecast, 2020-2030
    • 7.2.1 Flixonase/Flonase/Flonase OTC (Fluticasone Propionate) Forecast 2020-2030
    • 7.2.2 Nasonex (Mometasone) Forecast 2020-2030
    • 7.2.3 Avamys/Veramyst (Fluticasone Furoate) Forecast 2020-2030
    • 7.2.4 Rhinocort (Budesonide) Forecast 2020-2030
    • 7.2.5 Nasacort/Nasacort-OTC (Triamcinolone) Forecast 2020-2030
    • 7.2.6 Omnaris (Ciclesonide) Forecast 2020-2030
    • 7.2.7 Beconase/Beconaes AQ (Beclometasone) Forecast 2020-2030
    • 7.2.8 Qnasl (Beclometasone) Forecast 2020-2030
    • 7.2.9 Zetonna (Ciclesonide) Forecast 2020-2030
    • 7.2.10 Others Forecast 2020-2030

8 Oral Antihistamines Forecast 2020-2030

  • 8.1 Global Allergic Rhinitis Drugs Market for Oral Antihistamines Segment: Recovery Forecasts (V,U, W, L)
  • 8.2 Leading Oral Antihistamines Products Forecast, 2020-2030
    • 8.2.1 Allegra/Allegra-D/Allegra OTC (Fexofenadine) Forecast 2020-2030
    • 8.2.2 Claritin/Claritin OTC (Loratadine) Forecast 2020-2030
    • 8.2.3 Zyrtec/Zyrtec D (Cetirizine) Forecast 2020-2030
    • 8.2.4 Xyzal (Levocetirizine) Forecast 2020-2030
    • 8.2.5 Clarinex (Desloratadine) Forecast 2020-2030
    • 8.2.6 Allelock (Olopatadine) Forecast 2020-2030
    • 8.2.7 Ebastel (Ebastine) Forecast 2020-2030
    • 8.2.8 Talion (Bepotastine) Forecast 2020-2030
    • 8.2.9 Others Forecast 2020-2030

9 Immunotherapy and Vaccines Forecast 2020-2030

  • 9.1 Global Allergic Rhinitis Drugs Market for Immunotherapy and Vaccines Segment: Recovery Forecasts (V,U, W, L)
  • 9.2 Leading Immunotherapy and Vaccines Products, Forecast 2020-2030
    • 9.2.1 Staloral (Grass Pollen Allergen Extract) Forecast 2020-2030
    • 9.2.2 Alutard SQ Forecast 2020-2030
    • 9.2.3 Grazax/Grastek (Timothy Grass Pollen Allergen Extract) Forecast 2020-2030
    • 9.2.4 Oralair Forecast 2020-2030
    • 9.2.5 Ragwitek Forecast 2020-2030
    • 9.2.6 Other Immunotherapy & Vaccines Forecast 2020-2030

10 Other Allergic Rhinitis Sub-Markets Forecast 2020-2030

  • 10.1 Global Allergic Rhinitis Drugs Market for Others Segment: Recovery Forecasts (V,U, W, L)

11 Regional and Leading National Allergic Rhinitis Drugs Market Forecasts 2020-2030

  • 11.1 Global Allergic Rhinitis Drugs Market Forecasts 2020-2030: Recovery Scenarios

12 North America Allergic Rhinitis Drugs Market by Country Market Share Forecast 2020-2030

  • 12.1 North America Allergic Rhinitis Drugs Market Forecasts 2020-2030: Recovery Scenarios
  • 12.2 North America Allergic Rhinitis Drugs Market Forecast by Sub Markets, 2020-2030
    • 12.2.1 North America Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR%): Recovery Scenarios (V, U, W, L)
  • 12.3 U.S. Allergic Rhinitis Drugs Market Forecast 2020-2030
    • 12.3.1 Recovery Scenarios (V, U, W, L): U.S. Allergic Rhinitis Market Forecast 2020-2030
  • 12.4 Canada Allergic Rhinitis Drugs Market Forecast 2020-2030
    • 12.4.1 Recovery Scenarios (V, U, W, L): Canada Allergic Rhinitis Market Forecast 2020-2030

13 Europe Allergic Rhinitis Drugs Market by Country Market Share Forecast 2020-2030

  • 13.1 Europe Allergic Rhinitis Drugs Market Forecasts 2020-2030: Recovery Scenarios
  • 13.2 Europe Allergic Rhinitis Drugs Market Forecast by Sub Markets, 2020-2030
    • 13.2.1 Europe Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR%): Recovery Scenarios (V, U, W, L)
  • 13.3 Germany Allergic Rhinitis Drugs Market Forecast 2020-2030
    • 13.3.1 Recovery Scenarios (V, U, W, L): Germany Allergic Rhinitis Market Forecast 2020-2030
  • 13.4 UK Allergic Rhinitis Drugs Market Forecast 2020-2030
    • 13.4.1 Recovery Scenarios (V, U, W, L): UK Allergic Rhinitis Market Forecast 2020-2030
  • 13.5 France Allergic Rhinitis Drugs Market Forecast 2020-2030
    • 13.5.1 Recovery Scenarios (V, U, W, L): France Allergic Rhinitis Market Forecast 2020-2030
  • 13.6 Italy Allergic Rhinitis Drugs Market Forecast 2020-2030
    • 13.6.1 Recovery Scenarios (V, U, W, L): Italy Allergic Rhinitis Market Forecast 2020-2030
  • 13.7 Spain Allergic Rhinitis Drugs Market Forecast 2020-2030
    • 13.7.1 Recovery Scenarios (V, U, W, L): Spain Allergic Rhinitis Market Forecast 2020-2030
  • 13.8 Belgium Allergic Rhinitis Drugs Market Forecast 2020-2030
    • 13.8.1 Recovery Scenarios (V, U, W, L): Belgium Allergic Rhinitis Market Forecast 2020-2030
  • 13.9 Switzerland Allergic Rhinitis Drugs Market Forecast 2020-2030
    • 13.9.1 Recovery Scenarios (V, U, W, L): Switzerland Allergic Rhinitis Market Forecast 2020-2030
  • 13.10 Rest of Europe Allergic Rhinitis Drugs Market Forecast 2020-2030
    • 13.10.1 Recovery Scenarios (V, U, W, L): Rest of Europe Allergic Rhinitis Market Forecast 2020-2030

14 Asia Pacific Allergic Rhinitis Drugs Market by Country Market Share Forecast 2020-2030

  • 14.1 Asia Pacific Allergic Rhinitis Drugs Market Forecasts 2020-2030: Recovery Scenarios
  • 14.2 Asia Pacific Allergic Rhinitis Drugs Market Forecast by Sub Markets, 2020-2030
  • 14.2.1 Asia Pacific Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR%): Recovery Scenarios (V, U, W, L)
  • 14.3 Japan Allergic Rhinitis Drugs Market Forecast 2020-2030
    • 14.3.1 Recovery Scenarios (V, U, W, L): Japan Allergic Rhinitis Market Forecast 2020-2030
  • 14.4 China Allergic Rhinitis Drugs Market Forecast 2020-2030
    • 14.4.1 Recovery Scenarios (V, U, W, L): China Allergic Rhinitis Market Forecast 2020-2030
  • 14.5 India Allergic Rhinitis Drugs Market Forecast 2020-2030
    • 14.5.1 Recovery Scenarios (V, U, W, L): India Allergic Rhinitis Market Forecast 2020-2030
  • 14.6 Rest of Asia Pacific Allergic Rhinitis Drugs Market Forecast 2020-2030
    • 14.6.1 Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Allergic Rhinitis Market Forecast 2020-2030

15 Latin America Allergic Rhinitis Drugs Market by Country Market Share Forecast 2020-2030

  • 15.1 Latin America Allergic Rhinitis Drugs Market Forecasts 2020-2030: Recovery Scenarios
  • 15.2 Latin America Allergic Rhinitis Drugs Market Forecast by Sub Markets, 2020-2030
    • 15.2.1 Latin America Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR%): Recovery Scenarios (V, U, W, L)
  • 15.3 Brazil Allergic Rhinitis Drugs Market Forecast 2020-2030
    • 15.3.1 Recovery Scenarios (V, U, W, L): Brazil Allergic Rhinitis Market Forecast 2020-2030
  • 15.4 Mexico Allergic Rhinitis Drugs Market Forecast 2020-2030
    • 15.4.1 Recovery Scenarios (V, U, W, L): Mexico Allergic Rhinitis Market Forecast 2020-2030
  • 15.5 Argentina Allergic Rhinitis Drugs Market Forecast 2020-2030
    • 15.5.1 Recovery Scenarios (V, U, W, L): Argentina Allergic Rhinitis Market Forecast 2020-2030
  • 15.6 Rest of Latin America Allergic Rhinitis Drugs Market Forecast 2020-2030
    • 15.6.1 Recovery Scenarios (V, U, W, L): Rest of Latin America Allergic Rhinitis Market Forecast 2020-2030

16 MEA Allergic Rhinitis Drugs Market by Country Market Share Forecast 2020-2030

  • 16.1 MEA Allergic Rhinitis Drugs Market Forecasts 2020-2030: Recovery Scenarios
  • 16.2 MEA Allergic Rhinitis Drugs Market Forecast by Sub Markets, 2020-2030
    • 16.2.1 Middle East and Africa Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR%): Recovery Scenarios (V, U, W, L)
  • 16.3 UAE Allergic Rhinitis Drugs Market Forecast 2020-2030
    • 16.3.1 Recovery Scenarios (V, U, W, L): UAE Allergic Rhinitis Market Forecast 2020-2030
  • 16.4 Saudi Arabia Allergic Rhinitis Drugs Market Forecast 2020-2030
    • 16.4.1 Recovery Scenarios (V, U, W, L): Saudi Arabia Allergic Rhinitis Market Forecast 2020-2030
  • 16.5 South Africa Allergic Rhinitis Drugs Market Forecast 2020-2030
    • 16.5.1 Recovery Scenarios (V, U, W, L): South Africa Allergic Rhinitis Market Forecast 2020-2030
  • 16.6 Rest of MEA Allergic Rhinitis Drugs Market Forecast 2020-2030
    • 16.6.1 Recovery Scenarios (V, U, W, L): Rest of Middle East and Africa Allergic Rhinitis Market Forecast 2020-2030

17 Leading Companies in the Allergic Rhinitis Drugs Market

  • 17.1 ALK-Abello A/S
    • 17.1.1 ALK-Abello A/S: Company Key Details
    • 17.1.2 ALK-Abello A/S: Company Overview
    • 17.1.3 ALK-Abello A/S Financials, 2015-2019
    • 17.1.4 ALK-Abello A/S: Recent Developments
  • 17.2 GSK
    • 17.2.1 GSK: Company Key Details
    • 17.2.2 GSK: Company Overview
    • 17.2.3 GSK Financials, 2015-2019
    • 17.2.4 GSK: Recent Developments
  • 17.3 Johnson & Johnson
    • 17.3.1 Johnson & Johnson: Company Key Details
    • 17.3.2 Johnson & Johnson: Company Overview
    • 17.3.3 Johnson & Johnson Financials, 2015-2019
    • 17.3.4 Johnson & Johnson: Recent Developments
  • 17.4 Kyowa Hakko Kirin
    • 17.4.1 Kyowa Hakko Kirin: Company Key Details
    • 17.4.2 Kyowa Hakko Kirin: Company Overview
    • 17.4.3 Kyowa Hakko Kirin Financials, 2015-2019
    • 17.4.4 Kyowa Hakko Kirin: Recent Developments
  • 17.5 Merck KGaA
    • 17.5.1 Merck KGaA: Company Key Details
    • 17.5.2 Merck KGaA: Company Overview
    • 17.5.3 Merck KGaA Financials, 2015-2019
    • 17.5.4 Merck KGaA: Recent Developments
  • 17.6 Sanofi
    • 17.6.1 Sanofi: Company Key Details
    • 17.6.2 Sanofi: Company Overview
    • 17.6.3 Sanofi Financials, 2015-2019
    • 17.6.4 Sanofi: Recent Developments
  • 17.7 Stallergenes Greer
    • 17.7.1 Stallergenes Greer: Company Key Details
    • 17.7.2 Stallergenes Greer: Company Overview
    • 17.7.3 Stallergenes Greer Financials, 2015-2019
    • 17.7.4 Stallergenes Greer: Recent Developments
  • 17.8 UCB S.A.
    • 17.8.1 UCB S.A.: Company Key Details
    • 17.8.2 UCB S.A.: Company Overview
    • 17.8.3 UCB S.A. Financials, 2015-2019
    • 17.8.4 UCB S.A.: Recent Developments
  • 17.9 Boehringer Ingelheim International GmbH
    • 17.9.1 Boehringer Ingelheim International GmbH: Company Key Details
    • 17.9.2 Boehringer Ingelheim International GmbH: Company Overview
    • 17.9.3 Boehringer Ingelheim International GmbH Financials, 2015-2019
    • 17.9.4 Boehringer Ingelheim International GmbH: Recent Developments
  • 17.10 Bayer AG
    • 17.10.1 Bayer AG: Company Key Details
    • 17.10.2 Bayer AG: Company Overview
    • 17.10.3 Bayer AG Financials, 2015-2019
    • 17.10.4 Bayer AG: Recent Developments
  • 17.11 Novartis AG
    • 17.11.1 Novartis AG: Company Key Details
    • 17.11.2 Novartis AG: Company Overview
    • 17.11.3 Novartis AG Financials, 2015-2019
    • 17.11.4 Novartis AG: Recent Developments
  • 17.12 AstraZeneca
    • 17.12.1 AstraZeneca: Company Key Details
    • 17.12.2 AstraZeneca: Company Overview
    • 17.12.3 AstraZeneca Financials, 2015-2019
    • 17.12.4 AstraZeneca: Recent Developments

18 Conclusion

  • 18.1 Associated Visiongain Reports
  • Visiongain Report Sales Order Form

19 Appendix A

  • 19.1 About Visiongain
    • Appendix B
  • 19.2 Visiongain report evaluation form

List of Tables

  • Table 1 Global Allergic Rhinitis Drugs Market, 2019-2030 (US$ million, CAGR %)
  • Table 2 Global Allergic Rhinitis Drugs Market Forecast by Sub Markets, 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 3 Intranasal Antihistamines Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 4 "V" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 5 "U" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 6 "W" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 7 "L" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 8 Dymista Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 9 Generic Intranasal Azelastine Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 10 Astepro Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 11 Patanase Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 12 Astelin Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 13 Others Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 14 Intranasal Corticosteroids Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 15 "V" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Corticosteroids Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 16 "U" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Corticosteroids Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 17 "W" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Corticosteroids Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 18 "L" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Corticosteroids Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 19 Flixonase/Flonase/Flonase OTC Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 20 Nasonex Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 21 Avamys/Veramyst Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 22 Rhinocort Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 23 Nasacort/Nasacort-OTC Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 24 Omnaris Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 25 Beconase/Beconaes AQ Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 26 Qnasl Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 27 Zetonna Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 28 Others Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 29 Oral Antihistamines Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 30 "V" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Oral Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 31 "U" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Oral Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 32 "W" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Oral Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 33 "L" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Oral Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 34 Allegra/Allegra-D/Allegra OTC Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 35 Claritin/Claritin OTC Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 36 Zyrtec/Zyrtec D Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 37 Xyzal Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 38 Clarinex Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 39 Allelock Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 40 Ebastel Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 41 Talion Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 42 Others Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 43 Immunotherapy and Vaccines Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 44 "V" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Immunotherapy and Vaccines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 45 "U" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Immunotherapy and Vaccines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 46 "W" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Immunotherapy and Vaccines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 47 "L" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Immunotherapy and Vaccines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 48 Staloral Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 49 Alutard SQ Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 50 Grazax/Grastek Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 51 Oralair Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 52 Ragwitek Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 53 Others Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 54 Others Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 55 "V" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 56 "U" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 57 "W" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 58 "L" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 59 Global Allergic Rhinitis Drugs Market CAGR Forecast by Region 2020, 2025, 2030 (%)
  • Table 60 "V" Shaped Recovery: Global Allergic Rhinitis Drugs Market Forecast by Region, 2020- 2030 (US$ million, AGR %,)
  • Table 61 "U" Shaped Recovery: Global Allergic Rhinitis Drugs Market Forecast by Region, 2020- 2030 (US$ million, AGR %,)
  • Table 62 "W" Shaped Recovery: Global Allergic Rhinitis Drugs Market Forecast by Region, 2020- 2030 (US$ million, AGR %,)
  • Table 63 "L" Shaped Recovery: Global Allergic Rhinitis Drugs Market Forecast by Region, 2020- 2030 (US$ million, AGR %,)
  • Table 64 "V" Shaped Recovery: North America Allergic Rhinitis Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %,)
  • Table 65 "U" Shaped Recovery: North America Allergic Rhinitis Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %,)
  • Table 66 "W" Shaped Recovery: North America Allergic Rhinitis Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %,)
  • Table 67 "L" Shaped Recovery: North America Allergic Rhinitis Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %,)
  • Table 68 North America Allergic Rhinitis Drugs Market Forecast by Sub Markets, 2020-2030 (US$ million, AGR %)
  • Table 69 North America Allergic Rhinitis Drugs Market by Sub Markets: CAGR% (2020-2025, 2025-2030, 2020-2030)
  • Table 70 "V" Shaped Recovery: North America Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 71 "U" Shaped Recovery: North America Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 72 "W" Shaped Recovery: North America Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 73 "L" Shaped Recovery: North America Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 74 U.S. Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 75 "V" Shaped Recovery: U.S. Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 76 "U" Shaped Recovery: U.S. Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 77 "W" Shaped Recovery: U.S. Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 78 "L" Shaped Recovery: U.S. Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 79 Canada Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 80 "V" Shaped Recovery: Canada Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 81 "U" Shaped Recovery: Canada Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 82 "W" Shaped Recovery: Canada Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 83 "L" Shaped Recovery: Canada Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 84 "V" Shaped Recovery: Europe Allergic Rhinitis Drugs Market Forecast by Country, 2020- 2030 (US$ million, AGR %,)
  • Table 85 "U" Shaped Recovery: Europe Allergic Rhinitis Drugs Market Forecast by Country, 2020- 2030 (US$ million, AGR %,)
  • Table 86 "W" Shaped Recovery: Europe Allergic Rhinitis Drugs Market Forecast by Country, 2020- 2030 (US$ million, AGR %,)
  • Table 87 "L" Shaped Recovery: Europe Allergic Rhinitis Drugs Market Forecast by Country, 2020- 2030 (US$ million, AGR %,)
  • Table 88 Europe Allergic Rhinitis Drugs Market Forecast by Sub Markets, 2020-2030 (US$ million, AGR %)
  • Table 89 Europe Allergic Rhinitis Drugs Market by Sub Markets: CAGR% (2020-2025, 2025-2030, 2020-2030)
  • Table 90 "V" Shaped Recovery: Europe Allergic Rhinitis Market Forecast by Sub-Markets, 2020- 2030 (US$ million, AGR %, CAGR%)
  • Table 91 "U" Shaped Recovery: Europe Allergic Rhinitis Market Forecast by Sub-Markets, 2020- 2030 (US$ million, AGR %, CAGR%)
  • Table 92 "W" Shaped Recovery: Europe Allergic Rhinitis Market Forecast by Sub-Markets, 2020- 2030 (US$ million, AGR %, CAGR%)
  • Table 93 "L" Shaped Recovery: Europe Allergic Rhinitis Market Forecast by Sub-Markets, 2020- 2030 (US$ million, AGR %, CAGR%)
  • Table 94 Germany Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 95 "V" Shaped Recovery: Germany Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 96 "U" Shaped Recovery: Germany Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 97 "W" Shaped Recovery: Germany Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 98 "L" Shaped Recovery: Germany Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 99 UK Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 100 "V" Shaped Recovery: UK Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 101 "U" Shaped Recovery: UK Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 102 "W" Shaped Recovery: UK Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 103 "L" Shaped Recovery: UK Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 104 France Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 105 "V" Shaped Recovery: France Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 106 "U" Shaped Recovery: France Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 107 "W" Shaped Recovery: France Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 108 "L" Shaped Recovery: France Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 109 Italy Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 110 "V" Shaped Recovery: Italy Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 111 "U" Shaped Recovery: Italy Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 112 "W" Shaped Recovery: Italy Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 113 "L" Shaped Recovery: Italy Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 114 Spain Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 115 "V" Shaped Recovery: Spain Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 116 "U" Shaped Recovery: Spain Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 117 "W" Shaped Recovery: Spain Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 118 "L" Shaped Recovery: Spain Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 119 Belgium Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 120 "V" Shaped Recovery: Belgium Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 121 "U" Shaped Recovery: Belgium Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 122 "W" Shaped Recovery: Belgium Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 123 "L" Shaped Recovery: Belgium Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 124 Switzerland Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 125 "V" Shaped Recovery: Switzerland Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 126 "U" Shaped Recovery: Switzerland Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 127 "W" Shaped Recovery: Switzerland Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 128 "L" Shaped Recovery: Switzerland Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 129 Rest of Europe Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 130 "V" Shaped Recovery: Rest of Europe Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 131 "U" Shaped Recovery: Rest of Europe Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 132 "W" Shaped Recovery: Rest of Europe Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 133 "L" Shaped Recovery: Rest of Europe Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 134 "V" Shaped Recovery: Asia Pacific Allergic Rhinitis Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %,)
  • Table 135 "U" Shaped Recovery: Asia Pacific Allergic Rhinitis Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %,)
  • Table 136 "W" Shaped Recovery: Asia Pacific Allergic Rhinitis Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %,)
  • Table 137 "L" Shaped Recovery: Asia Pacific Allergic Rhinitis Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %,)
  • Table 138 Asia Pacific Allergic Rhinitis Drugs Market Forecast by Sub Markets, 2020-2030 (US$ million, AGR %)
  • Table 139 Asia Pacific Allergic Rhinitis Drugs Market by Sub Markets: CAGR% (2020-2025, 2025-2030, 2020-2030)
  • Table 140 "V" Shaped Recovery: Asia Pacific Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 141 "U" Shaped Recovery: Asia Pacific Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 142 "W" Shaped Recovery: Asia Pacific Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 143 "L" Shaped Recovery: Asia Pacific Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 144 Japan Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 145 "V" Shaped Recovery: Japan Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 146 "U" Shaped Recovery: Japan Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 147 "W" Shaped Recovery: Japan Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 148 "L" Shaped Recovery: Japan Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 149 China Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 150 "V" Shaped Recovery: China Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 151 "U" Shaped Recovery: China Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 152 "W" Shaped Recovery: China Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 153 "L" Shaped Recovery: China Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 154 India Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 155 "V" Shaped Recovery: India Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 156 "U" Shaped Recovery: India Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 157 "W" Shaped Recovery: India Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 158 "L" Shaped Recovery: India Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 159 Rest of Asia Pacific Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 160 "V" Shaped Recovery: Rest of Asia Pacific Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 161 "U" Shaped Recovery: Rest of Asia Pacific Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 162 "W" Shaped Recovery: Rest of Asia Pacific Allergic Rhinitis Market Forecast 2020- 2030 (US$ million, AGR %, CAGR %)
  • Table 163 "L" Shaped Recovery: Rest of Asia Pacific Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 164 "V" Shaped Recovery: Latin America Allergic Rhinitis Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %,)
  • Table 165 "U" Shaped Recovery: Latin America Allergic Rhinitis Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %,)
  • Table 166 "W" Shaped Recovery: Latin America Allergic Rhinitis Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %,)
  • Table 167 "L" Shaped Recovery: Latin America Allergic Rhinitis Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %,)
  • Table 168 Latin America Allergic Rhinitis Drugs Market Forecast by Sub Markets, 2020-2030 (US$ million, AGR %)
  • Table 169 Latin America Allergic Rhinitis Drugs Market by Sub Markets: CAGR% (2020-2025, 2025-2030, 2020-2030)
  • Table 170 "V" Shaped Recovery: Latin America Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 171 "U" Shaped Recovery: Latin America Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 172 "W" Shaped Recovery: Latin America Allergic Rhinitis Market Forecast by Sub- Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 173 "L" Shaped Recovery: Latin America Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 174 Brazil Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 175 "V" Shaped Recovery: Brazil Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 176 "U" Shaped Recovery: Brazil Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 177 "W" Shaped Recovery: Brazil Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 178 "L" Shaped Recovery: Brazil Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 179 Mexico Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 180 "V" Shaped Recovery: Mexico Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 181 "U" Shaped Recovery: Mexico Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 182 "W" Shaped Recovery: Mexico Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 183 "L" Shaped Recovery: Mexico Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 184 Argentina Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 185 "V" Shaped Recovery: Argentina Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 186 "U" Shaped Recovery: Argentina Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 187 "W" Shaped Recovery: Argentina Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 188 "L" Shaped Recovery: Argentina Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 189 Rest of Latin America Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 190 "V" Shaped Recovery: Rest of Latin America Allergic Rhinitis Market Forecast 2020- 2030 (US$ million, AGR %, CAGR %)
  • Table 191 "U" Shaped Recovery: Rest of Latin America Allergic Rhinitis Market Forecast 2020- 2030 (US$ million, AGR %, CAGR %)
  • Table 192 "W" Shaped Recovery: Rest of Latin America Allergic Rhinitis Market Forecast 2020- 2030 (US$ million, AGR %, CAGR %)
  • Table 193 "L" Shaped Recovery: Rest of Latin America Allergic Rhinitis Market Forecast 2020- 2030 (US$ million, AGR %, CAGR %)
  • Table 194 "V" Shaped Recovery: MEA Allergic Rhinitis Drugs Market Forecast by Country, 2020- 2030 (US$ million, AGR %,)
  • Table 195 "U" Shaped Recovery: MEA Allergic Rhinitis Drugs Market Forecast by Country, 2020- 2030 (US$ million, AGR %,)
  • Table 196 "W" Shaped Recovery: MEA Allergic Rhinitis Drugs Market Forecast by Country, 2020- 2030 (US$ million, AGR %,)
  • Table 197 "L" Shaped Recovery: MEA Allergic Rhinitis Drugs Market Forecast by Country, 2020- 2030 (US$ million, AGR %,)
  • Table 198 MEA Allergic Rhinitis Drugs Market Forecast by Sub Markets, 2020-2030 (US$ million, AGR %)
  • Table 199 MEA Allergic Rhinitis Drugs Market by Sub Markets: CAGR% (2020-2025, 2025-2030, 2020-2030)
  • Table 200 "V" Shaped Recovery: Middle East and Africa Allergic Rhinitis Market Forecast by Sub- Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 201 "U" Shaped Recovery: Middle East and Africa Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 202 "W" Shaped Recovery: Middle East and Africa Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 203 "L" Shaped Recovery: Middle East and Africa Allergic Rhinitis Market Forecast by Sub- Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 204 UAE Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 205 "V" Shaped Recovery: UAE Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 206 "U" Shaped Recovery: UAE Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 207 "W" Shaped Recovery: UAE Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 208 "L" Shaped Recovery: UAE Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 209 Saudi Arabia Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 210 "V" Shaped Recovery: Saudi Arabia Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 211 "U" Shaped Recovery: Saudi Arabia Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 212 "W" Shaped Recovery: Saudi Arabia Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 213 "L" Shaped Recovery: Saudi Arabia Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 214 South Africa Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 215 "V" Shaped Recovery: South Africa Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 216 "U" Shaped Recovery: South Africa Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 217 "W" Shaped Recovery: South Africa Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 218 "L" Shaped Recovery: South Africa Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 219 Rest of MEA Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 220 "V" Shaped Recovery: Rest of Middle East and Africa Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 221 "U" Shaped Recovery: Rest of Middle East and Africa Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 222 "W" Shaped Recovery: Rest of Middle East and Africa Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 223 "L" Shaped Recovery: Rest of Middle East and Africa Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 224 ALK-Abello A/S: Key Details (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 225 ALK-Abello A/S: Financials, 2015-2019 (DKK million, AGR %)
  • Table 226 GSK: Key Details (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 227 GSK: Financials, 2015-2019 (US$ million, AGR %)
  • Table 228 Johnson & Johnson: Key Details (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 229 Johnson & Johnson: Financials, 2015-2019 (US$ million, AGR %)
  • Table 230 Kyowa Hakko Kirin: Key Details (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 231 Kyowa Hakko Kirin: Financials, 2015-2019 (millions of yen, AGR %)
  • Table 232 Merck KGaA: Key Details (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 233 Merck KGaA: Financials, 2015-2019 (? million, AGR %)
  • Table 234 Sanofi: Key Details (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 235 Sanofi: Financials, 2015-2019 (? million, AGR %)
  • Table 236 Stallergenes Greer: Key Details (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 237 Stallergenes Greer: Financials, 2015-2019 (? million, AGR %)
  • Table 238 UCB S.A.: Key Details (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 239 UCB S.A.: Financials, 2015-2019 (? million, AGR %)
  • Table 240 Boehringer Ingelheim International GmbH: Key Details (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 241 Boehringer Ingelheim International GmbH: Financials, 2015-2019 (? million, AGR %)
  • Table 242 Bayer AG: Key Details (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 243 Bayer AG: Financials, 2015-2019 (? million, AGR %)
  • Table 244 Novartis AG: Key Details (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 245 Novartis AG: Financials, 2015-2019 (US$ million, AGR %)
  • Table 246 AstraZeneca: Key Details (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 247 AstraZeneca: Financials, 2015-2019 (US$ million, AGR %)
  • Table 248 Global Allergic Rhinitis Drugs Market CAGR Forecast by Region 2020, 2025, 2030 (%)

List of Figures

  • Figure 1 Global Allergic Rhinitis Drugs Market Segmentation
  • Figure 2 Role of Mast Cells and IgE in Allergic Rhinitis
  • Figure 3 Leading Antihistamines for Allergic Rhinitis
  • Figure 4 Leading Corticosteroids for Allergic Rhinitis,
  • Figure 5 Global Allergic Rhinitis Drugs Market Forecast by Sub Markets, 2020-2030 (US$ million, AGR %)
  • Figure 6 Global Allergic Rhinitis Drugs Market Share Forecast by Sub Markets, 2020, 2025, 2030 (%)
  • Figure 7 Intranasal Antihistamines Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 8 "V" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 9 "U" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 10 "W" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 11 "L" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 12 Dymista Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 13 Generic Intranasal Azelastine Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 14 Astepro Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 15 Patanase Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 16 Astelin Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 17 Others Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 18 Intranasal Corticosteroids Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 19 "V" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Corticosteroids Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 20 "U" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Corticosteroids Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 21 "W" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Corticosteroids Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 22 "L" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Corticosteroids Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 23 Flixonase/Flonase/Flonase OTC Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 24 Nasonex Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 25 Avamys/Veramyst Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 26 Rhinocort Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 27 Nasacort/Nasacort-OTC Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 28 Omnaris Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 29 Beconase/Beconaes AQ Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 30 Qnasl Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 31 Zetonna Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 32 Others Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 33 Oral Antihistamines Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 34 "V" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Oral Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 35 "U" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Oral Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 36 "W" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Oral Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 37 "L" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Oral Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 38 Allegra/Allegra-D/Allegra OTC Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 39 Claritin/Claritin OTC Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 40 Zyrtec/Zyrtec D Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 41 Xyzal Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 42 Clarinex Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 43 Allelock Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 44 Ebastel Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 45 Talion Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 46 Others Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 47 Immunotherapy and Vaccines Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 48 "V" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Immunotherapy and Vaccines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 49 "U" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Immunotherapy and Vaccines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 50 "W" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Immunotherapy and Vaccines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 51 "L" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Immunotherapy and Vaccines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 52 Staloral Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 53 Alutard SQ Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 54 Grazax/Grastek Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 55 Oralair Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 56 Ragwitek Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 57 Others Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 58 Others Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 59 "V" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 60 "U" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 61 "W" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 62 "L" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 63 Global Allergic Rhinitis Drugs Market Forecast by Region 2020-2030 (US$ million, AGR %)
  • Figure 64 Global Allergic Rhinitis Drugs Market Share Forecast by Region 2020, 2025, 2030 (%)
  • Figure 65 North America Allergic Rhinitis Drugs Market Forecast by Country 2020-2030 (US$ million, AGR %)
  • Figure 66 North America Allergic Rhinitis Drugs Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 67 North America Allergic Rhinitis Drugs Market Forecast by Sub Markets, 2020-2030 (US$ million, AGR%)
  • Figure 68 "V" Shaped Recovery: North America Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR%)
  • Figure 69 "U" Shaped Recovery: North America Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR%)
  • Figure 70 "W" Shaped Recovery: North America Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR%)
  • Figure 71 "L" Shaped Recovery: North America Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR%)
  • Figure 72 U.S. Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 73 "V" Shaped Recovery: U.S. Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 74 "U" Shaped Recovery: U.S. Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 75 "W" Shaped Recovery: U.S. Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 76 "L" Shaped Recovery: U.S. Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 77 Canada Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 78 "V" Shaped Recovery: Canada Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 79 "U" Shaped Recovery: Canada Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 80 "W" Shaped Recovery: Canada Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 81 "L" Shaped Recovery: Canada Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 82 Europe Allergic Rhinitis Drugs Market Forecast by Country 2020-2030 (US$ million, AGR %)
  • Figure 83 Europe Allergic Rhinitis Drugs Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 84 Europe Allergic Rhinitis Drugs Market Forecast by Sub Markets, 2020-2030 (US$ million, AGR%)
  • Figure 85 "V" Shaped Recovery: Europe Allergic Rhinitis Market Forecast by Sub-Markets, 2020- 2030 (US$ million, AGR%)
  • Figure 86 "U" Shaped Recovery: Europe Allergic Rhinitis Market Forecast by Sub-Markets, 2020- 2030 (US$ million, AGR%)
  • Figure 87 "W" Shaped Recovery: Europe Allergic Rhinitis Market Forecast by Sub-Markets, 2020- 2030 (US$ million, AGR%)
  • Figure 88 "L" Shaped Recovery: Europe Allergic Rhinitis Market Forecast by Sub-Markets, 2020- 2030 (US$ million, AGR%)
  • Figure 89 Germany Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 90 "V" Shaped Recovery: Germany Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 91 "U" Shaped Recovery: Germany Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 92 "W" Shaped Recovery: Germany Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 93 "L" Shaped Recovery: Germany Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 94 UK Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 95 "V" Shaped Recovery: UK Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 96 "U" Shaped Recovery: UK Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 97 "W" Shaped Recovery: UK Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 98 "L" Shaped Recovery: UK Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 99 France Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 100 "V" Shaped Recovery: France Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 101 "U" Shaped Recovery: France Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 102 "W" Shaped Recovery: France Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 103 "L" Shaped Recovery: France Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 104 Italy Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 105 "V" Shaped Recovery: Italy Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 106 "U" Shaped Recovery: Italy Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 107 "W" Shaped Recovery: Italy Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 108 "L" Shaped Recovery: Italy Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 109 Spain Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 110 "V" Shaped Recovery: Spain Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 111 "U" Shaped Recovery: Spain Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 112 "W" Shaped Recovery: Spain Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 113 "L" Shaped Recovery: Spain Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 114 Belgium Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 115 "V" Shaped Recovery: Belgium Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 116 "U" Shaped Recovery: Belgium Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 117 "W" Shaped Recovery: Belgium Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 118 "L" Shaped Recovery: Belgium Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 119 Switzerland Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 120 "V" Shaped Recovery: Switzerland Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 121 "U" Shaped Recovery: Switzerland Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 122 "W" Shaped Recovery: Switzerland Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 123 "L" Shaped Recovery: Switzerland Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 124 Rest of Europe Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 125 "V" Shaped Recovery: Rest of Europe Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 126 "U" Shaped Recovery: Rest of Europe Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 127 "W" Shaped Recovery: Rest of Europe Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 128 "L" Shaped Recovery: Rest of Europe Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 129 Asia Pacific Allergic Rhinitis Drugs Market Forecast by Country 2020-2030 (US$ million, AGR %)
  • Figure 130 Asia Pacific Allergic Rhinitis Drugs Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 131 Asia Pacific Allergic Rhinitis Drugs Market Forecast by Sub Markets, 2020-2030 (US$ million, AGR%)
  • Figure 132 "V" Shaped Recovery: Asia Pacific Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR%)
  • Figure 133 "U" Shaped Recovery: Asia Pacific Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR%)
  • Figure 134 "W" Shaped Recovery: Asia Pacific Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR%)
  • Figure 135 "L" Shaped Recovery: Asia Pacific Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR%)
  • Figure 136 Japan Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 137 "V" Shaped Recovery: Japan Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 138 "U" Shaped Recovery: Japan Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 139 "W" Shaped Recovery: Japan Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 140 "L" Shaped Recovery: Japan Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 141 China Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 142 "V" Shaped Recovery: China Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 143 "U" Shaped Recovery: China Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 144 "W" Shaped Recovery: China Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 145 "L" Shaped Recovery: China Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 146 India Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 147 "V" Shaped Recovery: India Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 148 "U" Shaped Recovery: India Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 149 "W" Shaped Recovery: India Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 150 "L" Shaped Recovery: India Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 151 Rest of Asia Pacific Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 152 "V" Shaped Recovery: Rest of Asia Pacific Allergic Rhinitis Market Forecast, 2020- 2030 (US$ million, AGR%)
  • Figure 153 "U" Shaped Recovery: Rest of Asia Pacific Allergic Rhinitis Market Forecast, 2020- 2030 (US$ million, AGR%)
  • Figure 154 "W" Shaped Recovery: Rest of Asia Pacific Allergic Rhinitis Market Forecast, 2020- 2030 (US$ million, AGR%)
  • Figure 155 "L" Shaped Recovery: Rest of Asia Pacific Allergic Rhinitis Market Forecast, 2020- 2030 (US$ million, AGR%)
  • Figure 156 Latin America Allergic Rhinitis Drugs Market Forecast by Country 2020-2030 (US$ million, AGR %)
  • Figure 157 Latin America Allergic Rhinitis Drugs Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 158 Latin America Allergic Rhinitis Drugs Market Forecast by Sub Markets, 2020-2030 (US$ million, AGR%)
  • Figure 159 "V" Shaped Recovery: Latin America Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR%)
  • Figure 160 "U" Shaped Recovery: Latin America Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR%)
  • Figure 161 "W" Shaped Recovery: Latin America Allergic Rhinitis Market Forecast by Sub- Markets, 2020-2030 (US$ million, AGR%)
  • Figure 162 "L" Shaped Recovery: Latin America Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR%)
  • Figure 163 Brazil Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 164 "V" Shaped Recovery: Brazil Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 165 "U" Shaped Recovery: Brazil Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 166 "W" Shaped Recovery: Brazil Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 167 "L" Shaped Recovery: Brazil Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 168 Mexico Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 169 "V" Shaped Recovery: Mexico Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 170 "U" Shaped Recovery: Mexico Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 171 "W" Shaped Recovery: Mexico Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 172 "L" Shaped Recovery: Mexico Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 173 Argentina Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 174 "V" Shaped Recovery: Argentina Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 175 "U" Shaped Recovery: Argentina Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 176 "W" Shaped Recovery: Argentina Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 177 "L" Shaped Recovery: Argentina Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 178 Rest of Latin America Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 179 "V" Shaped Recovery: Rest of Latin America Allergic Rhinitis Market Forecast, 2020- 2030 (US$ million, AGR%)
  • Figure 180 "U" Shaped Recovery: Rest of Latin America Allergic Rhinitis Market Forecast, 2020- 2030 (US$ million, AGR%)
  • Figure 181 "W" Shaped Recovery: Rest of Latin America Allergic Rhinitis Market Forecast, 2020- 2030 (US$ million, AGR%)
  • Figure 182 "L" Shaped Recovery: Rest of Latin America Allergic Rhinitis Market Forecast, 2020- 2030 (US$ million, AGR%)
  • Figure 183 MEA Allergic Rhinitis Drugs Market Forecast by Country 2020-2030 (US$ million, AGR %)
  • Figure 184 MEA Allergic Rhinitis Drugs Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 185 MEA Allergic Rhinitis Drugs Market Forecast by Sub Markets, 2020-2030 (US$ million, AGR%)
  • Figure 186 "V" Shaped Recovery: Middle East and Africa Allergic Rhinitis Market Forecast by Sub- Markets, 2020-2030 (US$ million, AGR%)
  • Figure 187 "U" Shaped Recovery: Middle East and Africa Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR%)
  • Figure 188 "W" Shaped Recovery: Middle East and Africa Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR%)
  • Figure 189 "L" Shaped Recovery: Middle East and Africa Allergic Rhinitis Market Forecast by Sub- Markets, 2020-2030 (US$ million, AGR%)
  • Figure 190 UAE Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 191 "V" Shaped Recovery: UAE Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 192 "U" Shaped Recovery: UAE Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 193 "W" Shaped Recovery: UAE Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 194 "L" Shaped Recovery: UAE Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 195 Saudi Arabia Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 196 "V" Shaped Recovery: Saudi Arabia Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 197 "U" Shaped Recovery: Saudi Arabia Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 198 "W" Shaped Recovery: Saudi Arabia Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 199 "L" Shaped Recovery: Saudi Arabia Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 200 South Africa Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 201 "V" Shaped Recovery: South Africa Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 202 "U" Shaped Recovery: South Africa Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 203 "W" Shaped Recovery: South Africa Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 204 "L" Shaped Recovery: South Africa Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 205 Rest of MEA Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 206 "V" Shaped Recovery: Rest of Middle East and Africa Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 207 "U" Shaped Recovery: Rest of Middle East and Africa Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 208 "W" Shaped Recovery: Rest of Middle East and Africa Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 209 "L" Shaped Recovery: Rest of Middle East and Africa Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 210 ALK-Abello A/S: Financials, 2015-2019 (DKK million, AGR %)
  • Figure 211 GSK: Financials, 2015-2019 (US$ million, AGR %)
  • Figure 212 Johnson & Johnson: Financials, 2015-2019 (US$ million, AGR %)
  • Figure 213 Kyowa Hakko Kirin: Financials, 2015-2019 (millions of yen, AGR %)
  • Figure 214 Merck KGaA: Financials, 2015-2019 (? million, AGR %)
  • Figure 215 Sanofi: Financials, 2015-2019 (? million, AGR %)
  • Figure 216 Stallergenes Greer: Financials, 2015-2018 (? million, AGR %)
  • Figure 217 UCB S.A.: Financials, 2015-2019 (? million, AGR %)
  • Figure 218 Boehringer Ingelheim International GmbH: Financials, 2015-2019 (? million, AGR %)
  • Figure 219 Bayer AG: Financials, 2015-2019 (? million, AGR %)
  • Figure 220 Novartis AG: Financials, 2015-2019 (US$ million, AGR %)
  • Figure 221 AstraZeneca: Financials, 2015-2019 (US$ million, AGR %)
  • Figure 222 Global Allergic Rhinitis Drugs Market Forecast by Region 2020-2030 (US$ million, AGR %)
  • Figure 223 Global Allergic Rhinitis Drugs Market Share Forecast by Region 2020, 2025, 2030 (%)